The country's first group standard for the "Technical Guidelines for Non-Clinical Safety of Oligonucleotide Drugs" has been released
The 9th China Nucleic Acid Drug Conference opened in Tianjin on September 17. The Tianjin Economic and Technological Development Zone Nucleic Acid Pharmaceutical Industrial Park and the Tianjin Nucleic Acid Industry Innovation Service Center were officially inaugurated, and the country's first group standard for the "Technical Guidelines for Non-Clinical Safety of Oligonucleotide Drugs" was released. Three key projects were signed on-site, with a cooperation scale exceeding 100 million yuan, covering areas such as the construction of production and manufacturing bases, development of new nucleic acid drugs and vaccines, and research and development of coronary artery-like organ nucleic acid drugs